Ibogaine-associated ventricular tachyarrhythmias

Clinical Toxicology

Volumn 50, Issue 2, 2012, Pages 157-

  Pleskovic, Ales ^a   Gorjup, Vojka ^a   Brvar, M ^a   Kozelj, G ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; COCAINE; DIAMORPHINE; IBOGAINE; METHADONE; NORIBOGAINE;

ABSTINENCE; ADULT; CARDIOVERSION; CASE REPORT; DEFECATION; DEFIBRILLATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; MALE; MICTURITION; QT PROLONGATION; SINGLE DRUG DOSE; SINUS BRADYCARDIA; UNCONSCIOUSNESS;

ADULT; ELECTROCARDIOGRAPHY; HUMANS; IBOGAINE; MALE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 84856942515     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2011.647031     Document Type: Letter

References (5)

1. Hoelen D, Spiering W, Valk G. Long-QT syndrome induced by the antiaddiction drug ibogaine. N Engl J Med 2009; 360:308-309.
2. Maas U, Strubelt S. Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction. Med Hypotheses 2006; 67:960-964. (Pubitemid 44062110)
3. Voigt L, Coromilas J, Saul BI, Kassotis J. Amiodarone-induced torsade de pointes during bladder irrigation: an unusual presentation-a case report. Angiology 2003; 54:229-231. (Pubitemid 36350695)
4. Martins JB, Zipes DP, Lund DD. Distribution of local repolarization changes produced by efferent vagal stimulation in the canine ventricles. J Am Coll Cardiol 1983; 2:1191-1199. (Pubitemid 14249606)
5. Mash DC, Kovera CA, Pablo J, Tyndale RF, Ervin FD, Williams IC, Singleton EG, Mayor M: Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary eff cacy measures. Ann N Y Acad Sci 2000; 914:394-401.